Coronavirus Assay Kits

Screening for small molecule and antibody inhibitors is an important factor in facilitating the discovery of treatments and vaccines for the novel coronavirus disease, COVID-19. ACE2, Spike, and the 3CL/Main protease are all potential therapeutic targets for the SARS-CoV-2 viral infection triggering this malady. BPS Bioscience offers multiple assay kits for testing interactions with these targets and their respective pathways. These kits are offered in a variety of read-out detection methods including TR-FRET, fluorogenic, colorimetric, and chemiluminescence. These kits are ideal for use in validation studies and suitable for rapid high-throughput screening of SARS-CoV-2 inhibitors.

· Screen for compounds that inhibit the interaction between the ACE2 and Spike proteins
· Characterize inhibitors that bind to ACE2 and/or Spike
· Identify inhibitors of ACE2 activity
· Facilitate the identification and characterization of 3CL/Main protease inhibitors

Along with assay design, optimization, and validation, BPS offers screening and profiling services, and custom development capabilities.

If you don't see what you are looking for, it is likely in our pipeline. We are releasing new products on a weekly basis. Please visit back or contact us for more information.